NCT00709462 A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) Status COMPLETED Phase PHASE1
NCT00702299 Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer Status COMPLETED Phase PHASE1
NCT00699907 Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00693342 Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission Status WITHDRAWN Phase PHASE3
NCT00692900 Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer Status COMPLETED Phase PHASE1
NCT00686465 Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study Status COMPLETED Phase NA
NCT00684801 Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers Status COMPLETED Phase N/A
NCT00683241 A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer Status COMPLETED Phase PHASE1
NCT00672295 PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer Status COMPLETED Phase PHASE1
NCT00667641 Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors Status COMPLETED Phase PHASE1
NCT00664781 Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00662233 Combination Chemotherapy in Treating Patients With Sarcoma Status COMPLETED Phase EARLY_PHASE1
NCT00660842 Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer Status UNKNOWN Phase PHASE3
NCT00657878 Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval Status UNKNOWN Phase PHASE3
NCT00653328 Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma Status TERMINATED Phase PHASE2
NCT00652899 Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer Status TERMINATED Phase PHASE2